Share on StockTwits

Nu Skin Enterprises (NYSE:NUS) is scheduled to release its earnings data on Tuesday, May 6th. Nu Skin Enterprises has set its Q1 guidance at $0.90-0.94 EPS.Parties interested in registering for the company’s conference call can do so using this link.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Monday, March 3rd. The company reported $2.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.03. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.07 billion. During the same quarter in the previous year, the company posted $0.97 earnings per share. The company’s revenue for the quarter was up 82.3% on a year-over-year basis. On average, analysts expect Nu Skin Enterprises to post $6.25 EPS for the current fiscal year and $7.07 EPS for the next fiscal year.

Shares of Nu Skin Enterprises (NYSE:NUS) opened at 87.60 on Monday. Nu Skin Enterprises has a 52 week low of $53.77 and a 52 week high of $140.50. The stock has a 50-day moving average of $83.16 and a 200-day moving average of $100.6. The company has a market cap of $5.151 billion and a P/E ratio of 14.74.

NUS has been the subject of a number of recent research reports. Analysts at Canaccord Genuity raised their price target on shares of Nu Skin Enterprises from $78.00 to $93.00 in a research note on Monday, March 24th. They now have a “hold” rating on the stock. On the ratings front, analysts at Deutsche Bank cut their price target on shares of Nu Skin Enterprises from $115.00 to $110.00 in a research note on Tuesday, March 4th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $112.69.

Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.